Neelima I Wellcome Trust Grant - Recipient

CSM I PRINCE2 I Wellcome Trust Grant - RecipientI Research Management I PI I Social Listening Pharma

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

Why should I pay for your technical glitch swiggy, order placed took the order still another same order comes up at the door which has to be cancelled. still asking the cancellation amount #swiggy #consumercourt

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

@Swiggy U need to work with your team especially the customer care.
Please see the comments how they are harassing a customer, this issue was widely reported still ur team wants me to refund the money.. U have lost more money than that fee u imposed
@SwiggyCares

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

https://t.co/xeKbzJaoGg "Broke Down Swiggy's App": Man's Post About Multiple Orders Goes Viral

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

IndiGo flight supposed to take off at 6:20 AM. Pilot just announced the First Officer is stuck in traffic.
Sir, are we flying or carpooling today? ✈️🚗
#OnlyInIndia #FlightDelayed #IndiGoChronicles

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

Most pathetic service by @_yesmadam ..your professional dont even turn up and when you call the customer serivce they disconnect your phone several time..I mean never had this issue with @urbanclap ..urbanclap is such a professional org, they value their customers like anything..

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

📷 Track the Buzz: Dive into discussions on AML, CAR-T therapies, and more.
Start tracking today and never miss a moment of the #ASH24 dialogue!
📷 DM us for a demo or visit https://t.co/WkfJvALw6f to learn more!
#ASH24 #Hematology #CancerResearch #Cancer #Oncology #AI

[KOL Pulse AI @KolPulseAI]

Follow the Physicians leading the #ASH24 discussions @VincentRK @majorajay @RahulBanerjeeMD @HadidiSamer @szusmani @DrMiguelPerales @AaronGoodman33 @VPrasadMDMPH

[KOL Pulse AI @KolPulseAI]

Prepping for #ASH24?
Here's a helpful list of Digital Opinion Leaders to follow and links to their pre-conference analysis of key abstracts:

1. Aaron Goodman (@AaronGoodman33):
- Highlighted key abstract on high risk smoldering myeloma, including data showing majority don't progress at 3 years [Source](https://t.co/5RmW3ReUPm)
- Criticized use of CAR-T in smoldering myeloma studies [Source](https://t.co/0PLWlzMWOS)
- Shared analysis of POLARIX 5-year follow-up data for DLBCL [Source](https://t.co/p6Feh75GOE)
2. Samer Al Hadidi (@HadidiSamer):
- Provided a comprehensive top 10 ASH24 abstracts for plasma cell disorders/multiple myeloma [Source](https://t.co/Wev0p7nxPm)
- Highlighted ANDROMEDA overall survival results [Source](https://t.co/Co94V1j3Ll)
- Discussed PANGEA-2 model for predicting smoldering myeloma progression [Source](https://t.co/FFLsLWidlD)
3. Rahul Banerjee (@RahulBanerjeeMD):
- Shared detailed analysis of top 10 myeloma abstracts focusing on response assessments, optimizing bispecific antibodies, and practice-changing studies [Source](https://t.co/iw5tsyzNkV)
- Highlighted urine-free IMWG response criteria study [Source](https://t.co/1Q3JBvpqsG)
- Discussed AQUILA trial of daratumumab in high-risk smoldering myeloma [Source](https://t.co/nxv3m3zywo)
4. Muzaffar Qazilbash (@Transplant_Doc):
- Shared insights on impact of previous HDM/ASCT on PFS with BCMA-directed CAR-T therapy [Source](https://t.co/NxYM8DFOV2)
- Highlighted study on 24-hour urine testing in myeloma response assessments [Source](https://t.co/E2uU12ZLz3)
- Discussed MRD analysis from Phase III Cepheus Trial [Source](https://t.co/t4pkogFWnT)
5. Ben Derman (@bdermanmd):
- Highlighted key abstracts on Dara-R vs Rd in frail patients, Talquetamab bridging before BCMA CAR T, and Anito-cel Phase 2 results [Source](https://t.co/UKRJoyagHk)
6. Raj Chakraborty (@rajshekharucms):
- Provided insights on multiple studies including MASTER trial, GMMG-HD7, DREAMM7, AQUILA trial, and IFM 2017-03 trial [Source](https://t.co/As1xURFqlm)
7. Mike Thompson (@mtmdphd):
- Shared a comprehensive list of important abstracts covering NDMM, RRMM, and basic/translational research [Source](https://t.co/9KSAzn2d4T)
8. Saad Z. Usmani (@szusmani):
- Compiled a "best of ASH24" abstract list covering clinical and basic/translational research in NDMM and RRMM [Source](https://t.co/84xyaUToSR)

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

🚀 Excited to see how @KolPulseAI is transforming the game in medical insights! With its advanced analytics, it's empowering pharma to make data-driven decisions with precision.🎯
Stay ahead with us—where innovation meets impact!
https://t.co/WkfJvALw6f
#Pharma

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

Unlock Every Twitter Insight from Conferences with @KolPulseAI
Every reaction at a conference matters!📊KOL Pulse AI ensures no tweet, comment, or mention slips through the cracks. It captures and analyzes every interaction, turning raw data into actionable insights. #AI #Data

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

🌟Attending pharma conferences? Make the most of it with KOL Pulse AI!

📄 Download accurate, AI-powered Conference Reports featuring
✅ Top KOL insights
✅ Key sessions & trends
✅ Actionable analytics
🔗 https://t.co/WkfJvALw6f

#HealthTech #KOLAnalytics @KolPulseAI #Pharma

[LARVOL @Larvol]

LARVOL is excited to formalise its tagline leveraging AI to revolutionise cancer data analytics with 80% of subscriptions and we want YOU to be a part of this exciting journey!

What's your take on LARVOL's new potential tagline for its AI-powered Cancer Data initiative?

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

🔍 Dive into the latest buzz ahead of #ASCO2024! Join 2500+ oncologists exploring key discussions on X, dissected by @LARVOL. Don't miss out on pre-ASCO 2024 insights: https://t.co/pCx7Fn76DZ 👁️‍🗨️ #Oncology #CancerResearch #clincaltrials

[LARVOL @Larvol]

Ready for the @ASCO 2024?

Take a moment to explore the key discussions from 2500+ leading oncologists on X, focusing on the top trials and influencers which have been analyzed by @LARVOL.

Click here for the pre-ASCO 2024 insights: https://t.co/aJ1Mcf4Y0x

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

Gratitude 🙏 @Larvol @brunolarvol #VirtualReality #rxxo

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

Our Larvol team is diving deep into #ASCO24 data, curating the top trials data. Cutting-edge insights are coming your way! Stay tuned https://t.co/QoUOSGnTiN
#ASCO24 #ASCO
#Oncology
#CancerResearch
#CancerCare
#MedicalConference
#Oncologist
#ClinicalTrials
#CancerTreatment

[ONCO BRUNO @brunolarvol]

@Larvol @ASCO

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

"Immersive, efficient, and productive - that's how I'd describe my experience with Larvol! Working in virtual reality has revolutionized the workflow. No more distractions just focused collaboration and creativity. #VirtualReality #Larvol #FutureOfWork 🚀💼"

[Rashmi Kamath @RashmiKamath10]

@Larvol Culture #HappyHour #virtualmeeting #workroommeeting #oculusquest @brunolarvol @PoojaPr19148609 @RubeenaKaz45172 @linhinVR @Debarat07333230 @Jud_Prz @Phaneesha_b @reenath35289442 @MarkW_G @Larvol

[OncoHost @OncoHost]

Our PROPHETIC trial was one of the most talked about trials by the top influencers at #AACR24 📢 Thank you @larvol for compiling and sharing this data.

https://t.co/qppRg8eg1r

#cancerresearch #AI #NSCLC #biomarkers

[Neelima I Wellcome Trust Grant - Recipient @reshma20201]

Excited for @ASCO 2024! 🌟Save the date for May 31 - June 4 in Chicago. 🏙️The latest session titles are out, promising valuable insights for the oncology community. Stay tuned for insights💫#ASCO24 #ASCO2024 #Oncology #CancerResearch #MedicalConference #Oncologist @Larvol